Kwality Pharmaceuticals Limited (BOM:539997)

Market Cap	10.05B
Revenue (ttm)	4.02B
Net Income (ttm)	434.15M
Shares Out	10.38M
EPS (ttm)	41.81
PE Ratio	23.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,905
Average Volume	15,570
Open	962.00
Previous Close	988.05
Day's Range	962.00 - 981.90
52-Week Range	596.05 - 1,235.00
Beta	-0.25
RSI	45.46
Earnings Date	Oct 20, 2025

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally. It offers its products in various dosage forms, including liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments/cream, external preparations, ORS, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized and covid products, syrups, daunorubicin, and other various categories, such ...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 806
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539997

Financial Performance

In 2024, Kwality Pharmaceuticals's revenue was 3.70 billion, an increase of 20.52% compared to the previous year's 3.07 billion. Earnings were 398.45 million, an increase of 67.44%.